drugset / Trial / NCT02707978
F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this research study is to evaluate tau distribution in the brain of subjects with: FTD caused by different genetic mutations, any mutation carriers (with or without symptoms), any non-mutation carrier, any sporadic FTD, normal controls.
Timeline
- Start
- 2017-09-30
- Primary completion
- 2020-09-30
- Completion
- 2020-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | 240 mbq | Intravenous |
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | 370 mbq | Intravenous |